Casey Lynch Insider Profile
4 Followers
Casey Lynch, CEO, Director at IRulya Therapeutics, holds 1.18M shares in IRulya Therapeutics (Ticker: IRLA), holds ― shares in Longboard Pharmaceuticals (Ticker: LBPH).
Casey Lynch's Trading History
| IRLAIRulya Therapeutics | Nov 19, 2021 | CEO, Director | Uninformative Buy | 27.60K | $46.99M | |
| LBPHLongboard Pharmaceuticals | ― | ― | ― | ― |
You May Also Like
Casey Lynch insider profile FAQ
What stocks does Casey Lynch hold?
Casey Lynch holds: IRLA, LBPH stocks.
What was Casey Lynch’s latest transaction?
Casey Lynch’s latest transaction was an Uninformative Buy of $27.60K.
What is Casey Lynch's role in IRulya Therapeutics?
Casey Lynch's role in IRulya Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
